Brixadi was tentatively approved by the FDA for treatment of moderate to severe opioid use disorder in December 2018, but is not eligible for ...
Braeburn Seeks Final Approval on Injectable Buprenorphine
- Written by: Drug News Feed
- Category: Drug News
- Hits: 467